One of the latest research also showed a new duty for SIRT3 in oral carcinogenesis as a promoter of cell proliferation and survival, therefore suggesting SIRT3 as a novel possible therapeutic objective to treat oral cancer [24]. The gene discussed is SIRT3; the disease is lip and oral cavity carcinoma.